0001193125-18-103331 Sample Contracts

Surface Oncology, Inc. Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • March 30th, 2018 • Surface Oncology, Inc. • Biological products, (no disgnostic substances) • New York

Surface Oncology, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of common stock, par value $0.0001 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).

AutoNDA by SimpleDocs
Re: Contingent Employment Agreement Termination Letter
Contingent Employment Agreement Termination Letter • March 30th, 2018 • Surface Oncology, Inc. • Biological products, (no disgnostic substances)

Reference is hereby made to that certain Employment Agreement (the “Agreement”) dated as of November 23, 2016, by and between Surface Oncology, Inc. (the “Company”), and you.

STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • March 30th, 2018 • Surface Oncology, Inc. • Biological products, (no disgnostic substances)

THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 29, 2018 (the “Effective Date”), by and between Surface Oncology, Inc., a Delaware corporation (the “Company”) and Novartis Institutes for Biomedical Research, Inc. (“Purchaser”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!